Noninvasive pulsatile flow estimation for an implantable rotary blood pump.

Graduate School of Biomedical Engineering, University of New South Wales, Sydney NSW 2052, Australia.
Conference proceedings: ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference 02/2007; 2007:1018-21. DOI: 10.1109/IEMBS.2007.4352467
Source: PubMed

ABSTRACT A noninvasive approach to the task of pulsatile flow estimation in an implantable rotary blood pump (iRBP) has been proposed. Employing six fluid solutions representing a range of viscosities equivalent to 20-50% blood hematocrit (HCT), pulsatile flow data was acquired from an in vitro mock circulatory loop. The entire operating range of the pump was examined, including flows from -2 to 12 L/min. Taking the pump feedback signals of speed and power, together with the HCT level, as input parameters, several flow estimate models were developed via system identification methods. Three autoregressive with exogenous input (ARX) model structures were evaluated: structures I and II used the input parameters directly; structure II incorporated additional terms for HCT; and the third structure employed as input a non-pulsatile flow estimate equation. Optimal model orders were determined, and the associated models yielded minimum mean flow errors of 5.49% and 0.258 L/min for structure II, and 5.77% and 0.270 L/min for structure III, when validated on unseen data. The models developed in this study present a practical method of accurately estimating iRBP flow in a pulsatile environment.

  • [Show abstract] [Hide abstract]
    ABSTRACT: A control system for rotary ventricular assist devices was developed to automatically regulate the pumping speed of the device to avoid ventricular suction. The control system comprises a suction detector and a fuzzy logic controller (FLC). The suction detector can correctly classify pump flow patterns, using a discriminant analysis (DA) model that combines several indices derived from the pump flow signal, to classify the pump status as one of the following: no suction (NS), moderate suction (MS), and severe suction (SS). The discriminant scores, which are the output of the suction detector, were used as inputs to the FLC. Based on this information, the controller updates pump speed, providing adequate flow and pressure perfusion to the patient. The performance of the control system was tested in simulations over a wide range of physiological conditions, including hypertension, exercise, and strenuous exercising for healthy, sick, and very sick hearts, using a lumped parameter model of the circulatory system coupled with a left ventricular assist device. The controller was able to maintain cardiac output and mean arterial pressure within acceptable physiologic ranges, while avoiding suction, demonstrating the feasibility of the proposed control system.
    IEEE transactions on bio-medical engineering 11/2008; 56(3):656-65. · 2.15 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Accurate noninvasive average flow and differential pressure estimation of implantable rotary blood pumps (IRBPs) is an important practical element for their physiological control. While most attempts at developing flow and differential pressure estimate models have involved purely empirical techniques, dimensional analysis utilizes theoretical principles of fluid mechanics that provides valuable insights into parameter relationships. Based on data obtained from a steady flow mock loop under a wide range of pump operating points and fluid viscosities, flow and differential pressure estimate models were thus obtained using dimensional analysis. The algorithm was then validated using data from two other VentrAssist IRBPs. Linear correlations between estimated and measured pump flow over a flow range of 0.5 to 8.0 L/min resulted in a slope of 0.98 ( R(2) = 0.9848). The average flow error was 0.20 +/- 0.14 L/min (mean +/- standard deviation) and the average percentage error was 5.79%. Similarly, linear correlations between estimated and measured pump differential pressure resulted in a slope of 1.027 ( R(2) = 0.997) over a pressure range of 60 to 180 mmHg. The average differential pressure error was 1.84 +/- 1.54 mmHg and the average percentage error was 1.51%.
    IEEE transactions on bio-medical engineering 08/2008; 55(8):2094-101. · 2.15 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Rotary type left ventricular assist devices have mitigated the problem of durability associated with earlier pulsatile pumps and demonstrated improved survival. However, the compromise is the loss of pulsatility due to continuous flow and retained percutaneous driveline leading to increased mortality and morbidity. Lack of pulsatility is implicated in increased gastrointestinal bleeding, aortic incompetence, and diastolic hypertension. We present a novel, wirelessly powered, ultra-compact, implantable physiologic controller capable of running a left ventricular assist device in a pulsatile mode with wireless power delivery. The schematic of our system was laid out on a circuit board to wirelessly receive power and run a left ventricular assist device with required safety and backup measures. We have embedded an antenna and wireless network for telemetry. Multiple signal processing steps and controlling algorithm were incorporated. The controller was tested in in vitro and in vivo experiments. The controller drove left ventricular assist devices continuously for 2 weeks in an in vitro setup and in vivo without any failure. Our controller is more power efficient than the current Food and Drug Administration-approved left ventricular assist device controllers. When used with electrocardiography synchronization, the controller allowed on-demand customization of operation with instantaneous flow and revolutions per minute changes, resulting in a pulsatile flow with adjustable pulse pressure. Our test results prove the system to be remarkably safe, accurate, and efficient. The unique combination of wireless powering and small footprint makes this system an ideal totally implantable physiologic left ventricular assist device system.
    The Journal of thoracic and cardiovascular surgery 10/2013; · 3.41 Impact Factor

Full-text (2 Sources)

Available from
Jun 2, 2014